Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Transplantation | 4 | 2022 | 4214 | 0.860 |
Why?
|
Version, Fetal | 2 | 2020 | 21 | 0.840 |
Why?
|
Breech Presentation | 2 | 2020 | 39 | 0.830 |
Why?
|
Databases, Genetic | 4 | 2024 | 1736 | 0.830 |
Why?
|
High-Throughput Nucleotide Sequencing | 8 | 2015 | 3614 | 0.670 |
Why?
|
Hyperparathyroidism | 1 | 2020 | 337 | 0.650 |
Why?
|
Hyperuricemia | 1 | 2021 | 224 | 0.630 |
Why?
|
Graft Rejection | 2 | 2022 | 4427 | 0.620 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2020 | 343 | 0.580 |
Why?
|
Sequence Analysis, RNA | 4 | 2021 | 2001 | 0.570 |
Why?
|
Neurofibromin 1 | 1 | 2018 | 190 | 0.560 |
Why?
|
Uric Acid | 1 | 2021 | 803 | 0.510 |
Why?
|
Nystagmus, Congenital | 1 | 2015 | 9 | 0.500 |
Why?
|
Sequence Analysis, DNA | 9 | 2019 | 4710 | 0.490 |
Why?
|
Molecular Sequence Annotation | 2 | 2018 | 524 | 0.480 |
Why?
|
Hereditary Central Nervous System Demyelinating Diseases | 1 | 2015 | 42 | 0.480 |
Why?
|
Genetic Association Studies | 3 | 2024 | 2717 | 0.470 |
Why?
|
Genetic Variation | 5 | 2018 | 6549 | 0.440 |
Why?
|
Neurofibromatosis 1 | 1 | 2018 | 560 | 0.440 |
Why?
|
Early Detection of Cancer | 2 | 2024 | 3164 | 0.410 |
Why?
|
Genetic Predisposition to Disease | 8 | 2020 | 17767 | 0.400 |
Why?
|
Prenatal Diagnosis | 1 | 2019 | 1264 | 0.390 |
Why?
|
RNA, Small Untranslated | 1 | 2012 | 77 | 0.380 |
Why?
|
Dystonia | 1 | 2015 | 366 | 0.380 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2013 | 161 | 0.370 |
Why?
|
Viruses | 1 | 2015 | 376 | 0.370 |
Why?
|
Microcephaly | 1 | 2015 | 425 | 0.360 |
Why?
|
Biological Evolution | 2 | 2015 | 1072 | 0.340 |
Why?
|
Decision Support Techniques | 1 | 2019 | 1991 | 0.320 |
Why?
|
Virus Diseases | 1 | 2015 | 719 | 0.320 |
Why?
|
Mutation, Missense | 3 | 2016 | 2564 | 0.310 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 2744 | 0.300 |
Why?
|
Craniofacial Abnormalities | 2 | 2023 | 315 | 0.300 |
Why?
|
Magnesium | 2 | 2022 | 809 | 0.300 |
Why?
|
Mutation | 10 | 2019 | 29929 | 0.290 |
Why?
|
Acute Coronary Syndrome | 1 | 2020 | 2181 | 0.290 |
Why?
|
Genome, Viral | 3 | 2016 | 660 | 0.280 |
Why?
|
Graft Survival | 3 | 2022 | 3794 | 0.270 |
Why?
|
Virus Replication | 5 | 2019 | 2430 | 0.270 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2019 | 2416 | 0.260 |
Why?
|
Israel | 4 | 2021 | 721 | 0.250 |
Why?
|
RNA, Bacterial | 2 | 2021 | 385 | 0.250 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6840 | 0.230 |
Why?
|
Predictive Value of Tests | 5 | 2024 | 15207 | 0.210 |
Why?
|
Ectodermal Dysplasia | 1 | 2023 | 106 | 0.210 |
Why?
|
MicroRNAs | 5 | 2019 | 3780 | 0.200 |
Why?
|
Genome-Wide Association Study | 4 | 2017 | 12601 | 0.200 |
Why?
|
Mycoplasma | 2 | 2012 | 138 | 0.190 |
Why?
|
Software | 2 | 2012 | 4416 | 0.190 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4492 | 0.180 |
Why?
|
Pedigree | 7 | 2020 | 4578 | 0.180 |
Why?
|
Magnesium Deficiency | 1 | 2020 | 48 | 0.180 |
Why?
|
Birth Intervals | 1 | 2020 | 51 | 0.180 |
Why?
|
Retrospective Studies | 10 | 2024 | 79984 | 0.180 |
Why?
|
RNA, Viral | 3 | 2021 | 2837 | 0.170 |
Why?
|
Humans | 49 | 2024 | 757566 | 0.170 |
Why?
|
Ribonuclease III | 2 | 2019 | 279 | 0.160 |
Why?
|
Phenotype | 7 | 2024 | 16533 | 0.160 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2019 | 86 | 0.160 |
Why?
|
Menstruation | 1 | 2020 | 307 | 0.160 |
Why?
|
Chikungunya virus | 2 | 2016 | 53 | 0.150 |
Why?
|
DEAD-box RNA Helicases | 2 | 2019 | 383 | 0.150 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2019 | 158 | 0.150 |
Why?
|
Hyperkeratosis, Epidermolytic | 1 | 2017 | 7 | 0.150 |
Why?
|
Jews | 2 | 2020 | 364 | 0.150 |
Why?
|
Genital Neoplasms, Female | 1 | 2023 | 532 | 0.150 |
Why?
|
Genetic Testing | 3 | 2023 | 3529 | 0.140 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 242 | 0.140 |
Why?
|
Elliptocytosis, Hereditary | 1 | 2017 | 29 | 0.140 |
Why?
|
Amniotic Fluid | 1 | 2019 | 378 | 0.140 |
Why?
|
Nephritis, Hereditary | 1 | 2017 | 78 | 0.140 |
Why?
|
Computational Biology | 4 | 2018 | 3501 | 0.140 |
Why?
|
Evolution, Molecular | 2 | 2016 | 1884 | 0.140 |
Why?
|
Codon | 1 | 2018 | 601 | 0.140 |
Why?
|
Ichthyosis | 1 | 2016 | 59 | 0.140 |
Why?
|
Mumps virus | 1 | 2016 | 23 | 0.130 |
Why?
|
Cohort Studies | 5 | 2024 | 41190 | 0.130 |
Why?
|
Leucovorin | 1 | 2018 | 642 | 0.130 |
Why?
|
Deafness | 1 | 2020 | 457 | 0.130 |
Why?
|
Calpain | 1 | 2016 | 145 | 0.130 |
Why?
|
Parity | 1 | 2019 | 924 | 0.130 |
Why?
|
DNA Mutational Analysis | 5 | 2017 | 4107 | 0.130 |
Why?
|
Complement Factor I | 1 | 2015 | 14 | 0.130 |
Why?
|
Mucopolysaccharidosis III | 1 | 2015 | 11 | 0.130 |
Why?
|
Murine hepatitis virus | 1 | 2015 | 19 | 0.130 |
Why?
|
Abortion, Spontaneous | 1 | 2020 | 530 | 0.120 |
Why?
|
Enterovirus B, Human | 1 | 2015 | 47 | 0.120 |
Why?
|
Hair | 1 | 2019 | 497 | 0.120 |
Why?
|
Parvovirus, Canine | 1 | 2014 | 2 | 0.120 |
Why?
|
Exons | 2 | 2018 | 2392 | 0.120 |
Why?
|
Organometallic Compounds | 1 | 2018 | 648 | 0.120 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2015 | 57 | 0.120 |
Why?
|
Arboviruses | 1 | 2014 | 13 | 0.120 |
Why?
|
Alopecia | 1 | 2019 | 411 | 0.120 |
Why?
|
Arbovirus Infections | 1 | 2014 | 21 | 0.120 |
Why?
|
Female | 22 | 2024 | 389943 | 0.120 |
Why?
|
Adaptation, Biological | 1 | 2015 | 147 | 0.120 |
Why?
|
HIV | 2 | 2012 | 1582 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1135 | 0.120 |
Why?
|
Porokeratosis | 1 | 2013 | 3 | 0.110 |
Why?
|
Down-Regulation | 2 | 2019 | 2901 | 0.110 |
Why?
|
Desmoglein 1 | 1 | 2013 | 7 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2015 | 358 | 0.110 |
Why?
|
Acetyltransferases | 1 | 2015 | 231 | 0.110 |
Why?
|
RNA Viruses | 1 | 2015 | 110 | 0.110 |
Why?
|
Culicidae | 1 | 2014 | 108 | 0.110 |
Why?
|
Parathyroid Hormone | 1 | 2020 | 1796 | 0.110 |
Why?
|
Viral Nonstructural Proteins | 1 | 2015 | 223 | 0.110 |
Why?
|
Keratosis | 1 | 2013 | 80 | 0.110 |
Why?
|
Hypopigmentation | 1 | 2013 | 43 | 0.110 |
Why?
|
Fluorouracil | 1 | 2018 | 1636 | 0.110 |
Why?
|
Delivery, Obstetric | 1 | 2020 | 931 | 0.110 |
Why?
|
Pyrophosphatases | 1 | 2013 | 139 | 0.110 |
Why?
|
Hearing Loss | 1 | 2020 | 781 | 0.110 |
Why?
|
Calcification, Physiologic | 1 | 2013 | 170 | 0.110 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2017 | 378 | 0.110 |
Why?
|
Middle Aged | 11 | 2024 | 219192 | 0.110 |
Why?
|
Wasting Syndrome | 1 | 2013 | 97 | 0.110 |
Why?
|
Prenatal Care | 1 | 2020 | 1129 | 0.110 |
Why?
|
Neuroendocrine Tumors | 1 | 2019 | 641 | 0.100 |
Why?
|
Population Dynamics | 1 | 2015 | 306 | 0.100 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2013 | 198 | 0.100 |
Why?
|
RNA Editing | 1 | 2014 | 151 | 0.100 |
Why?
|
Pityriasis Rubra Pilaris | 1 | 2012 | 18 | 0.100 |
Why?
|
RNA-Binding Proteins | 2 | 2019 | 1896 | 0.100 |
Why?
|
Virulence | 1 | 2016 | 1298 | 0.100 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2152 | 0.100 |
Why?
|
Internet | 1 | 2024 | 3081 | 0.100 |
Why?
|
Placenta | 1 | 2021 | 1703 | 0.100 |
Why?
|
Immunoglobulins | 1 | 2015 | 859 | 0.100 |
Why?
|
Adenosine Deaminase | 1 | 2014 | 251 | 0.100 |
Why?
|
Pre-Eclampsia | 1 | 2021 | 1226 | 0.100 |
Why?
|
Linear Models | 1 | 2021 | 5856 | 0.100 |
Why?
|
Dermatitis | 1 | 2013 | 200 | 0.100 |
Why?
|
Retinitis Pigmentosa | 1 | 2015 | 397 | 0.090 |
Why?
|
Guanylate Cyclase | 1 | 2012 | 205 | 0.090 |
Why?
|
Syndrome | 2 | 2015 | 3261 | 0.090 |
Why?
|
Tubulin | 1 | 2015 | 692 | 0.090 |
Why?
|
Pancreatic Neoplasms | 2 | 2019 | 5348 | 0.090 |
Why?
|
INDEL Mutation | 1 | 2012 | 267 | 0.090 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2012 | 158 | 0.090 |
Why?
|
Kidney Diseases | 1 | 2021 | 2082 | 0.090 |
Why?
|
Peer Review, Research | 1 | 2014 | 340 | 0.090 |
Why?
|
Risk Assessment | 2 | 2024 | 23816 | 0.090 |
Why?
|
ROC Curve | 1 | 2018 | 3562 | 0.090 |
Why?
|
Antibodies | 1 | 2019 | 2420 | 0.090 |
Why?
|
Phylogeny | 2 | 2016 | 2774 | 0.090 |
Why?
|
Vaccinia virus | 1 | 2012 | 331 | 0.090 |
Why?
|
Genome, Human | 2 | 2014 | 4414 | 0.090 |
Why?
|
Ear, Inner | 1 | 2014 | 424 | 0.090 |
Why?
|
Gestational Age | 1 | 2019 | 3565 | 0.090 |
Why?
|
Recombination, Genetic | 1 | 2014 | 1526 | 0.090 |
Why?
|
Point Mutation | 1 | 2015 | 1594 | 0.080 |
Why?
|
Epithelium | 1 | 2014 | 1605 | 0.080 |
Why?
|
HIV-1 | 2 | 2019 | 6850 | 0.080 |
Why?
|
Male | 17 | 2024 | 358180 | 0.080 |
Why?
|
Registries | 2 | 2023 | 8164 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4159 | 0.080 |
Why?
|
Aged | 7 | 2024 | 167890 | 0.080 |
Why?
|
Ultrasonography | 1 | 2021 | 5951 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20037 | 0.080 |
Why?
|
Adult | 12 | 2023 | 219725 | 0.080 |
Why?
|
Ethics, Medical | 1 | 2013 | 783 | 0.070 |
Why?
|
Macular Degeneration | 1 | 2015 | 1001 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 2014 | 831 | 0.070 |
Why?
|
Host-Pathogen Interactions | 2 | 2014 | 1442 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12397 | 0.070 |
Why?
|
Protein Conformation | 1 | 2015 | 3966 | 0.070 |
Why?
|
Sequence Alignment | 1 | 2011 | 2177 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2024 | 4760 | 0.070 |
Why?
|
Base Sequence | 5 | 2015 | 12437 | 0.070 |
Why?
|
Lung | 2 | 2023 | 9973 | 0.070 |
Why?
|
Herpesvirus 4, Human | 1 | 2012 | 1075 | 0.070 |
Why?
|
Genomics | 3 | 2023 | 5788 | 0.070 |
Why?
|
Pregnancy | 4 | 2021 | 29712 | 0.070 |
Why?
|
Skin | 2 | 2017 | 4464 | 0.060 |
Why?
|
Gene Frequency | 1 | 2013 | 3612 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2023 | 9574 | 0.060 |
Why?
|
Incidence | 1 | 2024 | 21217 | 0.060 |
Why?
|
Antiviral Agents | 2 | 2015 | 3055 | 0.060 |
Why?
|
Molecular Sequence Data | 5 | 2016 | 17615 | 0.060 |
Why?
|
Risk Factors | 3 | 2024 | 73708 | 0.060 |
Why?
|
Coronary Vessels | 1 | 2016 | 3072 | 0.060 |
Why?
|
Skin Diseases | 1 | 2013 | 1088 | 0.060 |
Why?
|
Killer Cells, Natural | 1 | 2014 | 2200 | 0.060 |
Why?
|
Models, Molecular | 1 | 2015 | 5406 | 0.060 |
Why?
|
Genome | 1 | 2013 | 1739 | 0.060 |
Why?
|
Coronary Angiography | 1 | 2016 | 4451 | 0.060 |
Why?
|
Cell Line | 3 | 2015 | 15587 | 0.060 |
Why?
|
Hypersensitivity | 1 | 2013 | 1155 | 0.060 |
Why?
|
Pancreatectomy | 2 | 2019 | 808 | 0.060 |
Why?
|
Prognosis | 3 | 2020 | 29488 | 0.060 |
Why?
|
Transcription Factors | 2 | 2023 | 12092 | 0.050 |
Why?
|
Gene Expression Profiling | 3 | 2016 | 9403 | 0.050 |
Why?
|
Child, Preschool | 5 | 2020 | 42045 | 0.050 |
Why?
|
Family | 1 | 2013 | 3188 | 0.050 |
Why?
|
Genes, Homeobox | 1 | 2023 | 284 | 0.050 |
Why?
|
Models, Biological | 1 | 2018 | 9459 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2015 | 4407 | 0.050 |
Why?
|
Proteins | 1 | 2017 | 6024 | 0.050 |
Why?
|
Body Mass Index | 1 | 2019 | 12868 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2018 | 15774 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2018 | 6323 | 0.050 |
Why?
|
Genetic Markers | 2 | 2017 | 2608 | 0.040 |
Why?
|
Receptors, Thrombopoietin | 1 | 2021 | 160 | 0.040 |
Why?
|
Age of Onset | 2 | 2019 | 3296 | 0.040 |
Why?
|
HeLa Cells | 2 | 2019 | 3096 | 0.040 |
Why?
|
Antibodies, Fungal | 1 | 2019 | 34 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12078 | 0.040 |
Why?
|
Platelet Count | 1 | 2021 | 774 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2023 | 58558 | 0.040 |
Why?
|
beta Catenin | 1 | 2023 | 1043 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2021 | 64242 | 0.040 |
Why?
|
Keratin-1 | 1 | 2017 | 3 | 0.040 |
Why?
|
Keratin-10 | 1 | 2017 | 8 | 0.040 |
Why?
|
RNA, Untranslated | 1 | 2021 | 459 | 0.040 |
Why?
|
Face | 1 | 2023 | 1017 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2019 | 735 | 0.040 |
Why?
|
Genotype | 3 | 2019 | 12951 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2018 | 414 | 0.040 |
Why?
|
Animals | 8 | 2016 | 167718 | 0.030 |
Why?
|
Heredity | 1 | 2017 | 148 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6364 | 0.030 |
Why?
|
Specimen Handling | 1 | 2021 | 702 | 0.030 |
Why?
|
Pancreatic Ducts | 1 | 2018 | 329 | 0.030 |
Why?
|
Mumps Vaccine | 1 | 2016 | 16 | 0.030 |
Why?
|
Defective Viruses | 1 | 2016 | 89 | 0.030 |
Why?
|
Scalp | 1 | 2019 | 389 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14637 | 0.030 |
Why?
|
Young Adult | 3 | 2023 | 58755 | 0.030 |
Why?
|
Intermediate Filament Proteins | 1 | 2016 | 262 | 0.030 |
Why?
|
Tunisia | 1 | 2015 | 36 | 0.030 |
Why?
|
Portal Vein | 1 | 2018 | 429 | 0.030 |
Why?
|
Consensus Sequence | 1 | 2016 | 365 | 0.030 |
Why?
|
Caribbean Region | 1 | 2016 | 191 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13597 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 16881 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2012 | 7840 | 0.030 |
Why?
|
Vero Cells | 1 | 2016 | 482 | 0.030 |
Why?
|
Mutagenesis | 1 | 2019 | 1233 | 0.030 |
Why?
|
HIV Infections | 2 | 2019 | 17270 | 0.030 |
Why?
|
Pancreaticoduodenectomy | 1 | 2018 | 508 | 0.030 |
Why?
|
Vaccines, Attenuated | 1 | 2016 | 314 | 0.030 |
Why?
|
Hair Follicle | 1 | 2016 | 210 | 0.030 |
Why?
|
Mutagens | 1 | 2015 | 179 | 0.030 |
Why?
|
Rats, Inbred Lew | 1 | 2016 | 1154 | 0.030 |
Why?
|
Signal Transduction | 2 | 2014 | 23335 | 0.030 |
Why?
|
Cambodia | 1 | 2014 | 185 | 0.030 |
Why?
|
Breast | 1 | 2023 | 1961 | 0.030 |
Why?
|
Microbial Viability | 1 | 2015 | 238 | 0.030 |
Why?
|
Insect Vectors | 1 | 2014 | 134 | 0.030 |
Why?
|
Genetic Privacy | 1 | 2014 | 59 | 0.030 |
Why?
|
Aedes | 1 | 2014 | 97 | 0.030 |
Why?
|
Adolescent | 3 | 2020 | 87819 | 0.030 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2016 | 563 | 0.030 |
Why?
|
Myopathies, Structural, Congenital | 1 | 2014 | 103 | 0.030 |
Why?
|
Somatomedins | 1 | 2013 | 178 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2015 | 491 | 0.030 |
Why?
|
Skin Diseases, Genetic | 1 | 2013 | 49 | 0.030 |
Why?
|
Cicatrix | 1 | 2019 | 780 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2019 | 3415 | 0.030 |
Why?
|
Financing, Organized | 1 | 2014 | 204 | 0.030 |
Why?
|
Drug Combinations | 1 | 2018 | 2020 | 0.030 |
Why?
|
Polysaccharides | 1 | 2019 | 1007 | 0.030 |
Why?
|
Vestibule, Labyrinth | 1 | 2014 | 232 | 0.030 |
Why?
|
Heterozygote | 1 | 2019 | 2797 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 584 | 0.020 |
Why?
|
Blood Platelets | 1 | 2021 | 2476 | 0.020 |
Why?
|
Child | 5 | 2020 | 79782 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 1733 | 0.020 |
Why?
|
Bacteria | 1 | 2021 | 2196 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3591 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2796 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3510 | 0.020 |
Why?
|
Saliva | 1 | 2014 | 820 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 22022 | 0.020 |
Why?
|
Dogs | 1 | 2014 | 3838 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2904 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2015 | 12761 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 2014 | 755 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2012 | 656 | 0.020 |
Why?
|
Gene Deletion | 1 | 2017 | 2666 | 0.020 |
Why?
|
Mammals | 1 | 2014 | 1130 | 0.020 |
Why?
|
Epidemics | 1 | 2014 | 512 | 0.020 |
Why?
|
Mice | 4 | 2016 | 81066 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2019 | 2685 | 0.020 |
Why?
|
Cochlea | 1 | 2014 | 844 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2012 | 1494 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36270 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2809 | 0.020 |
Why?
|
Mass Screening | 1 | 2023 | 5412 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2015 | 11890 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5031 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2016 | 1756 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 25924 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 21990 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4110 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4257 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2834 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6757 | 0.020 |
Why?
|
Zebrafish | 1 | 2016 | 2992 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5638 | 0.020 |
Why?
|
Viral Load | 1 | 2014 | 3321 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10135 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12684 | 0.010 |
Why?
|
Retina | 1 | 2015 | 2637 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11082 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11063 | 0.010 |
Why?
|
Infant | 2 | 2013 | 36045 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9245 | 0.010 |
Why?
|
Rats | 1 | 2016 | 23676 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54092 | 0.010 |
Why?
|
Computer Simulation | 1 | 2012 | 6198 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11709 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10167 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39020 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2014 | 4673 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2018 | 15532 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15781 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18114 | 0.010 |
Why?
|
United States | 1 | 2023 | 71902 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 26176 | 0.010 |
Why?
|